NCT03103841

Brief Summary

Obstructive sleep apnoea (OSA) is a condition that affects around one in 20 children. In children with OSA, repeated episodes of airway obstruction can severely disturb and fragment sleep, leading to subsequent cognitive and behavioural problems . Epilepsy affects 60,000 children in the UK and up to 30% of children with epilepsy have learning problems. Evidence suggests that OSA is more common in children with epilepsy, such that sleep disturbance could account for some of the learning problems they experience. The aim of this study is to determine the prevalence of OSA in children with epilepsy. The investigators plan carry out detailed sleep studies in children with epilepsy and healthy controls to determine if children with epilepsy are more likely to have OSA than healthy children of the same age. OSA is almost always treatable and the benefits of detecting and treating the condition in healthy children are well-established. If OSA proves to be a common finding in children with epilepsy, it will be important to carry out further studies to see if treating the condition has beneficial effects on learning and behaviour. This project could lead doctors to target sleep-disordered breathing as a way of improving learning outcomes in children with epilepsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 12, 2016

Completed
4 months until next milestone

Study Start

First participant enrolled

March 31, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 6, 2017

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

March 28, 2023

Status Verified

April 1, 2022

Enrollment Period

5.6 years

First QC Date

December 12, 2016

Last Update Submit

March 27, 2023

Conditions

Keywords

Children

Outcome Measures

Primary Outcomes (1)

  • Apnea/Hypopnea index

    Measurement of presence and severity of obstructive sleep apnoea

    Over study duration - 2 years

Secondary Outcomes (5)

  • Total Sleep Time

    Over study duration - 2 years

  • Sleep Efficiency

    Over study duration - 2 years

  • Sleep Quality

    Up to 10 hours

  • Symptoms of OSA

    Over study duration - 2 years

  • Daytime Sleepiness

    Over study duration - 2 years

Other Outcomes (1)

  • Presence of epileptiform discharges during sleep

    Single point in time measurement - Sleep study [8 to 10 hour period of sleep data]

Study Arms (2)

Children and young people with epilepsy

Sleep studies \[Polysomnography\] to assess presence and severity of obstructive sleep apnoea in children with epilepsy compared with a healthy control group

Procedure: Sleep studies [Polysomnography]

Healthy controls

Sleep studies \[Polysomnography\] to assess presence and severity of obstructive sleep apnoea in children with epilepsy compared with a healthy control group

Procedure: Sleep studies [Polysomnography]

Interventions

Undertaking of sleep measurements by polysomnography and use of validated sleep questionnaires

Children and young people with epilepsyHealthy controls

Eligibility Criteria

Age5 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children with epilepsy

You may qualify if:

  • Diagnosis of primary epilepsy and attendance at Epilepsy clinic

You may not qualify if:

  • Neurological co-morbidity affecting muscle tone OR any Respiratory co-morbidity including any history of asthma, airborne allergy or sleep-disordered breathing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Hospital for Sick Children

Edinburgh, EH9 1LF, United Kingdom

Location

Related Publications (2)

  • Urquhart DS, Hill EA, Hill LE, Carruthers E, McLellan AE, Chin R, Shetty J. Adults with epilepsy appear to differ from children in regard to daytime sleepiness. J Clin Sleep Med. 2020 Aug 15;16(8):1393-1394. doi: 10.5664/jcsm.8528.

  • Urquhart DS, McLellan AE, Hill LE, Carruthers E, Hill EA, Chin RF, Shetty J. A case-control study to investigate the prevalence of obstructive sleep apnea and the utility of the Sleep-Related Breathing Disorder scale of the Pediatric Sleep Questionnaire in children and young people with epilepsy. J Clin Sleep Med. 2024 Jul 1;20(7):1039-1047. doi: 10.5664/jcsm.11054.

MeSH Terms

Conditions

EpilepsySleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesSleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake Disorders

Study Officials

  • Don S Urquhart, MD, FRCPCH

    NHS Lothian

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 12, 2016

First Posted

April 6, 2017

Study Start

March 31, 2017

Primary Completion

October 31, 2022

Study Completion

December 31, 2022

Last Updated

March 28, 2023

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations